Atriva Announces Exclusive Letter Agreement for Reverse Takeover Transaction
18 Sep 2023 //
GLOBENEWSWIRE
Edesa finds a signal in severely ill Covid-19 patients
21 Sep 2021 //
EVALUATE
Atriva Therapeutics begins patient dosing in phase II RESPIRE trial in Covid-19
14 Apr 2021 //
PHARMABIZ
Atriva Therapeutics Doses First Patient in Phase II RESPIRE trial in COVID-19
13 Apr 2021 //
DGAP
Artiva Biotherapeutics Raises $120 Million in Series B Financing
26 Feb 2021 //
BUSINESSWIRE